Compass Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Compass Therapeutics Inc 's ROA in the second quarter of 2026?
Compass Therapeutics Inc recorded a cumulative net loss of $-73 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -34.72%.

However, within the Healthcare sector 452 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3731, from total ROA ranking in the first quarter of 2026 at 4419.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	62.96 %	56.08 %	62.53 %	83.2 %	-24.78 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-73	-68	-66	-66	-62
Return On Assets (TTM)	-34.72 %	-35.29 %	-38.05 %	-42.83 %	-48.7 %
CMPX's Total Ranking	# 3731	# 4419	# 3932	# 4032	# 3992
Total Assets (TTM) in million	190	205	220	231	117
Seq. Total Assets Change	-7.31 %	-6.57 %	-5.05 %	98.17 %	-11.22 %
Seq. Net Income Change	-	-	-	-	-

CMPX's 5 Years Annual ROA >> Back to CMPX Management Effectiveness >> Compare CMPX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 50
Sector	# 453
Overall	# 3684

Return On Assets Statistics
High	Average	Low
1396.43 %	61.84 %	-118.36 %
(Mar 31 2020)		(Dec 31 2021)

Financial Statements
Compass Therapeutics Inc 's Assets	$ 190 million	CMPX's Balance sheet
Compass Therapeutics Inc 's Income	$ -25 million	Quarterly CMPX's Income Statement
CMPX's Income by Division		See CMPX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	62.53 %	-13.83 %	-20.96 %	29.01 %	196.19 %
Total Assets in million	220	135	157	198	154
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-66	-49	-42	-39	-82
Annual Return On Assets	-30.28 %	-36.55 %	-27.1 %	-19.77 %	-53.45 %

CMPX's 5 Years Annual ROA >> Back to CMPX Management Effectiveness >> Compare CMPX ROA to its Competitors

More Return On Assets Ratios
CMPX's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CMPX's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CMPX's Competitors
Subscribers only: Roa for Compass Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for CMPX's Customers

You may also want to know
CMPX's Roi	CMPX's Inventory Turnover Ratio	CMPX's Growth Rates	CMPX's Dividend Comparisons
	CMPX's Profitability Ratios	CMPX's Asset Turnover Ratio	CMPX's Dividend Growth
CMPX's Roe	CMPX's Valuation Ratios	CMPX's Financial Strength Ratios	CMPX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T01:11:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.